12.05.2011
- Japan's largest drugmaker Takeda Pharmaceutical is in talks to buy privately-held Swiss rival Nycomed in a deal that could be valued at about $14.2 billion, Bloomberg said, citing...
11.05.2011
- It was a most unusual road trip - Drivers on the highways of Europe were probably surprised to see the scaled-down equivalent of a bioprocessing production line rolling next to...
11.05.2011
- Boom Region - In 2011, the markets for bio-based materials are continuing to develop dynamically (with annual growth rates of 15-30 %). It is estimated that a global production...
04.05.2011
- Europe's largest biotech Actelion was dealt a blow when a jury in a Californian court said Japanese drugmaker Asahi Kasei should be awarded up to $547 million in a licensing...
02.05.2011
- Swiss biotech group Actelion is now facing a tougher battle at its annual general meeting this week after a jury decided Asahi Kasei Pharma Corporation should be awarded up to $547...
02.05.2011
- Swiss biotech group Actelion may appeal against a jury's decision in a Californian court to award Asahi Kasei Pharma Corporation up to $547 million in a dispute with Actelion unit...
27.04.2011
- U.S. hedge fund group Elliott Associates has raised its stake in Danish company Danisco to 4.9% to put pressure on DuPont to raise its bid for the food ingredients and enzymes...
08.04.2011
- We are the world's leading consulting and engineering company in the complex field of pharma and biotech.If you just count the consulting and engineering companies that focus...
04.04.2011
- French drugmaker Sanofi-Aventis completed its improved $20.1 billion offer for Genzyme allowing it to begin merging the U.S. biotech into its business and add rare diseases to its...
30.03.2011
- Certificates related to Sanofi-Aventis's $20.1 billion acquisition of U.S. biotech firm Genzyme could begin trading on Nasdaq as soon as April 4, depending on the outcome of its...
